Skip to main content

Table 1 Patient's clinical data.

From: MUC1 expression and anti-MUC1 serum immune response in head and neck squamous cell carcinoma (HNSCC): a multivariate analysis

Patient Number

Age

Sex

Localization

T stage

N stage

Metastasis

Clinical stage

Tumor differentiation

1

52

M

Larynx

1

0

0

I

Poorly

2

98

M

Larynx

1

0

0

I

Well

3

73

M

Larynx

1

0

0

I

Well

4

57

M

Oral cavity

2

0

0

II

Poorly

5

65

F

Larynx

2

0

0

II

Well

6

68

M

Oral cavity

2

0

0

II

Well

7

64

F

Oral cavity

2

0

0

II

Well

8

63

M

Pharynx

2

0

0

II

Well

9

50

M

Oral cavity

2

1

0

III

Moderately

10

64

M

Larynx

3

1

0

III

Well

11

48

F

Oral cavity

3

1

0

III

Poorly

12

47

F

Oral cavity

3

1

0

III

Well

13

77

M

Oral cavity

3

1

0

III

Poorly

14

59

M

Oral cavity

3

1

0

III

Well

15

69

F

Oral cavity

3

0

0

III

Well

16

56

M

Larynx

3

0

0

III

Moderately

17

65

M

Oral cavity

3

0

0

III

Well

18

40

F

Oral cavity

3

0

0

III

Poorly

19

56

M

Pharynx

3

0

0

III

Poorly

20

70

M

Larynx

3

0

0

III

Moderately

21

75

M

Pharynx

3

0

0

III

Well

22

65

M

Oral cavity

3

1

0

III

Well

23

60

F

Oral cavity

2

1

0

III

Moderately

24

56

M

Pharynx

4

0

0

IVA

Moderately

25

54

F

Pharynx

4

0

0

IVA

Poorly

26

55

M

Oral cavity

4

2

0

IVA

Moderately

27

65

M

Pharynx

4

2

0

IVA

Moderately

28

58

M

Larynx

4

0

0

IVA

Poorly

29

53

M

Larynx

4

0

0

IVA

Moderately

30

62

M

Oral cavity

4

2

0

IVA

ND

31

29

F

Oral cavity

3

2

0

IVA

Moderately

32

60

F

Oral cavity

3

2

0

IVA

Well

33

38

M

Pharynx

4

1

0

IVA

Poorly

34

62

F

Larynx

1

2

0

IVA

Moderately

35

68

M

Larynx

3

2

0

IVA

Moderately

36

68

M

Oral cavity

4

1

0

IVA

Moderately

37

50

M

Oral cavity

3

2

0

IVA

Poorly

38

61

F

Pharynx

2

2

0

IVA

Poorly

39

62

M

Larynx

3

2

0

IVA

Poorly

40

53

M

Larynx

4

2

0

IVA

Well

41

84

F

Larynx

4

0

0

IVA

Well

42

50

M

Oral cavity

4

0

0

IVA

Poorly

43

55

M

Oral cavity

4

0

0

IVA

Moderately

44

73

F

Oral cavity

4

1

0

IVA

Poorly

45

71

M

Oral cavity

4

0

0

IVA

Moderately

46

49

M

Oral cavity

4

0

0

IVA

Well

47

54

M

Oral cavity

4

2

0

IVA

Poorly

48

72

M

Pharynx

4

1

0

IVA

Moderately

49

59

M

Larynx

4

2

0

IVA

Moderately

50

68

M

Larynx

4

3

0

IVB

Moderately

51

54

M

Larynx

3

3

0

IVB

Moderately

52

61

M

Pharynx

4

3

0

IVB

Moderately

53

72

M

Oral cavity

3

3

1

IVC

Well

  1. Site, sex, clinical stage, T and N stage and tumor differentiation are included.